Literature DB >> 14622162

Blockade of noradrenergic receptors in the basolateral amygdala impairs taste memory.

M I Miranda1, R T LaLumiere, T V Buen, F Bermudez-Rattoni, J L McGaugh.   

Abstract

In conditioned taste aversion (CTA), a subject learns to associate a novel taste (conditioned stimulus, CS) with visceral malaise (unconditioned stimulus, US). Considerable evidence indicates that the noradrenergic system in the amygdala plays an important role in memory consolidation for emotionally arousing experiences. The specific aim of the present set of experiments was to determine the involvement of noradrenergic activity in the basolateral amygdala (BLA) during the US presentation and consolidation of CTA as well as during the consolidation of a nonaversive/incidental gustatory memory. Selective bilateral microinfusions of the beta-adrenergic antagonist propranolol administered into the BLA immediately before intraperitoneal (i.p.) lithium chloride (LiCl) injections disrupted CTA memory. Additionally, propranolol infused into the BLA immediately after a pre-exposure to the saccharin (CS) significantly attenuated latent inhibition. The present findings indicating that alterations in noradrenergic function in the BLA affect taste memory formation, provide additional evidence that the BLA plays a critical role in modulating the consolidation of memory and that the influence is mediated by interactions with other brain regions that support memory for different kinds of experiences.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14622162     DOI: 10.1046/j.1460-9568.2003.03008.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  32 in total

1.  Taste neophobia and c-Fos expression in the rat brain.

Authors:  Jian-You Lin; Chris Roman; Joe Arthurs; Steve Reilly
Journal:  Brain Res       Date:  2012-02-12       Impact factor: 3.252

2.  Enhancement of inhibitory avoidance and conditioned taste aversion memory with insular cortex infusions of 8-Br-cAMP: involvement of the basolateral amygdala.

Authors:  María I Miranda; James L McGaugh
Journal:  Learn Mem       Date:  2004 May-Jun       Impact factor: 2.460

3.  Post-retrieval propranolol treatment does not modulate reconsolidation or extinction of ethanol-induced conditioned place preference.

Authors:  Laura Font; Christopher L Cunningham
Journal:  Pharmacol Biochem Behav       Date:  2012-01-21       Impact factor: 3.533

4.  Memory-influencing intra-basolateral amygdala drug infusions modulate expression of Arc protein in the hippocampus.

Authors:  Christa K McIntyre; Teiko Miyashita; Barry Setlow; Kristopher D Marjon; Oswald Steward; John F Guzowski; James L McGaugh
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-14       Impact factor: 11.205

Review 5.  Protein synthesis inhibition and memory: formation vs amnesia.

Authors:  Paul E Gold
Journal:  Neurobiol Learn Mem       Date:  2007-12-03       Impact factor: 2.877

6.  Intra-amygdala injections of CREB antisense impair inhibitory avoidance memory: role of norepinephrine and acetylcholine.

Authors:  Clinton E Canal; Qing Chang; Paul E Gold
Journal:  Learn Mem       Date:  2008-08-26       Impact factor: 2.460

7.  Post-retrieval disruption of a cocaine conditioned place preference by systemic and intrabasolateral amygdala beta2- and alpha1-adrenergic antagonists.

Authors:  Rick E Bernardi; Andrey E Ryabinin; S Paul Berger; K Matthew Lattal
Journal:  Learn Mem       Date:  2009-11-25       Impact factor: 2.460

Review 8.  Emotional Modulation of Learning and Memory: Pharmacological Implications.

Authors:  Ryan T LaLumiere; James L McGaugh; Christa K McIntyre
Journal:  Pharmacol Rev       Date:  2017-07       Impact factor: 25.468

9.  Amphetamine-induced activation of neurons within the rat nucleus of the solitary tract.

Authors:  Caitlyn M Edwards; Julia Strother; Huiyuan Zheng; Linda Rinaman
Journal:  Physiol Behav       Date:  2019-03-01

Review 10.  Emotional modulation of the synapse.

Authors:  Jayme R McReynolds; Christa K McIntyre
Journal:  Rev Neurosci       Date:  2012       Impact factor: 4.353

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.